nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—CYP2C9—Gefitinib—lung cancer	0.0976	0.339	CbGbCtD
Cyclizine—CYP2C9—Teniposide—lung cancer	0.0946	0.329	CbGbCtD
Cyclizine—CYP2C9—Paclitaxel—lung cancer	0.0528	0.184	CbGbCtD
Cyclizine—CYP2C9—Cisplatin—lung cancer	0.0425	0.148	CbGbCtD
Cyclizine—SULT1E1—respiratory system—lung cancer	0.012	0.277	CbGeAlD
Cyclizine—SULT1E1—bronchus—lung cancer	0.00985	0.228	CbGeAlD
Cyclizine—SULT1E1—lung—lung cancer	0.00636	0.147	CbGeAlD
Cyclizine—Trimethaphan—CHRNB4—lung cancer	0.00439	0.34	CrCbGaD
Cyclizine—SULT1E1—lymph node—lung cancer	0.00435	0.101	CbGeAlD
Cyclizine—CYP2C9—mammary gland—lung cancer	0.00326	0.0754	CbGeAlD
Cyclizine—Trimethaphan—CHRNA3—lung cancer	0.00304	0.236	CrCbGaD
Cyclizine—HRH1—respiratory system—lung cancer	0.00214	0.0495	CbGeAlD
Cyclizine—HRH1—epithelium—lung cancer	0.00179	0.0414	CbGeAlD
Cyclizine—HRH1—trachea—lung cancer	0.00158	0.0366	CbGeAlD
Cyclizine—Angioedema—Topotecan—lung cancer	0.00124	0.00374	CcSEcCtD
Cyclizine—Dizziness—Pemetrexed—lung cancer	0.00122	0.00368	CcSEcCtD
Cyclizine—Convulsion—Vinblastine—lung cancer	0.00121	0.00365	CcSEcCtD
Cyclizine—Hypertension—Vinblastine—lung cancer	0.0012	0.00364	CcSEcCtD
Cyclizine—Urticaria—Teniposide—lung cancer	0.00119	0.00358	CcSEcCtD
Cyclizine—Erythema—Vinorelbine—lung cancer	0.00116	0.0035	CcSEcCtD
Cyclizine—Dermatitis bullous—Docetaxel—lung cancer	0.00115	0.00347	CcSEcCtD
Cyclizine—HRH1—lung—lung cancer	0.00114	0.0263	CbGeAlD
Cyclizine—Hepatobiliary disease—Gemcitabine—lung cancer	0.00113	0.0034	CcSEcCtD
Cyclizine—Bronchospasm—Etoposide—lung cancer	0.00112	0.00339	CcSEcCtD
Cyclizine—Agranulocytosis—Gemcitabine—lung cancer	0.00111	0.00336	CcSEcCtD
Cyclizine—Anaphylactic shock—Topotecan—lung cancer	0.00111	0.00334	CcSEcCtD
Cyclizine—Hypersensitivity—Teniposide—lung cancer	0.0011	0.00332	CcSEcCtD
Cyclizine—Nervous system disorder—Topotecan—lung cancer	0.00108	0.00328	CcSEcCtD
Cyclizine—Connective tissue disorder—Irinotecan—lung cancer	0.00108	0.00326	CcSEcCtD
Cyclizine—Skin disorder—Topotecan—lung cancer	0.00107	0.00325	CcSEcCtD
Cyclizine—Jaundice cholestatic—Doxorubicin—lung cancer	0.00107	0.00324	CcSEcCtD
Cyclizine—Nervous system disorder—Erlotinib—lung cancer	0.00107	0.00324	CcSEcCtD
Cyclizine—Asthenia—Teniposide—lung cancer	0.00107	0.00323	CcSEcCtD
Cyclizine—Skin disorder—Erlotinib—lung cancer	0.00106	0.00321	CcSEcCtD
Cyclizine—Angioedema—Vinorelbine—lung cancer	0.00106	0.0032	CcSEcCtD
Cyclizine—Pruritus—Teniposide—lung cancer	0.00106	0.00319	CcSEcCtD
Cyclizine—Depressed level of consciousness—Methotrexate—lung cancer	0.00105	0.00318	CcSEcCtD
Cyclizine—Connective tissue disorder—Gemcitabine—lung cancer	0.00105	0.00318	CcSEcCtD
Cyclizine—Hepatobiliary disease—Cisplatin—lung cancer	0.00105	0.00317	CcSEcCtD
Cyclizine—Paraesthesia—Vinblastine—lung cancer	0.00102	0.00309	CcSEcCtD
Cyclizine—Dyskinesia—Doxorubicin—lung cancer	0.001	0.00303	CcSEcCtD
Cyclizine—Hypertension—Vinorelbine—lung cancer	0.001	0.00302	CcSEcCtD
Cyclizine—Paraesthesia—Topotecan—lung cancer	0.000993	0.003	CcSEcCtD
Cyclizine—Insomnia—Erlotinib—lung cancer	0.00099	0.00299	CcSEcCtD
Cyclizine—Chills—Irinotecan—lung cancer	0.000986	0.00298	CcSEcCtD
Cyclizine—Connective tissue disorder—Cisplatin—lung cancer	0.00098	0.00296	CcSEcCtD
Cyclizine—Pain—Vinblastine—lung cancer	0.000974	0.00294	CcSEcCtD
Cyclizine—Constipation—Vinblastine—lung cancer	0.000974	0.00294	CcSEcCtD
Cyclizine—Hepatobiliary disease—Etoposide—lung cancer	0.000963	0.00291	CcSEcCtD
Cyclizine—Chills—Gemcitabine—lung cancer	0.00096	0.0029	CcSEcCtD
Cyclizine—Agranulocytosis—Etoposide—lung cancer	0.00095	0.00287	CcSEcCtD
Cyclizine—Anaphylactic shock—Vinorelbine—lung cancer	0.000946	0.00286	CcSEcCtD
Cyclizine—Constipation—Topotecan—lung cancer	0.000946	0.00286	CcSEcCtD
Cyclizine—Pain—Topotecan—lung cancer	0.000946	0.00286	CcSEcCtD
Cyclizine—Hepatobiliary disease—Paclitaxel—lung cancer	0.000944	0.00285	CcSEcCtD
Cyclizine—Injection site reaction—Doxorubicin—lung cancer	0.000938	0.00283	CcSEcCtD
Cyclizine—Constipation—Erlotinib—lung cancer	0.000936	0.00283	CcSEcCtD
Cyclizine—Pain—Erlotinib—lung cancer	0.000936	0.00283	CcSEcCtD
Cyclizine—Headache—Teniposide—lung cancer	0.000935	0.00282	CcSEcCtD
Cyclizine—Bronchospasm—Docetaxel—lung cancer	0.000933	0.00282	CcSEcCtD
Cyclizine—Eye disorder—Cisplatin—lung cancer	0.000932	0.00282	CcSEcCtD
Cyclizine—Erythema—Gemcitabine—lung cancer	0.000931	0.00281	CcSEcCtD
Cyclizine—Nervous system disorder—Vinorelbine—lung cancer	0.000928	0.0028	CcSEcCtD
Cyclizine—Tachycardia—Vinorelbine—lung cancer	0.000923	0.00279	CcSEcCtD
Cyclizine—Muscle spasms—Irinotecan—lung cancer	0.000919	0.00278	CcSEcCtD
Cyclizine—Skin disorder—Vinorelbine—lung cancer	0.000919	0.00278	CcSEcCtD
Cyclizine—Thrombophlebitis—Methotrexate—lung cancer	0.000914	0.00276	CcSEcCtD
Cyclizine—Hypotension—Vinorelbine—lung cancer	0.000884	0.00267	CcSEcCtD
Cyclizine—Connective tissue disorder—Paclitaxel—lung cancer	0.00088	0.00266	CcSEcCtD
Cyclizine—Urticaria—Topotecan—lung cancer	0.000879	0.00265	CcSEcCtD
Cyclizine—Erythema—Cisplatin—lung cancer	0.000868	0.00262	CcSEcCtD
Cyclizine—Eye disorder—Etoposide—lung cancer	0.000854	0.00258	CcSEcCtD
Cyclizine—Paraesthesia—Vinorelbine—lung cancer	0.00085	0.00257	CcSEcCtD
Cyclizine—Hypersensitivity—Vinblastine—lung cancer	0.000839	0.00253	CcSEcCtD
Cyclizine—Eye disorder—Paclitaxel—lung cancer	0.000837	0.00253	CcSEcCtD
Cyclizine—Muscle spasms—Cisplatin—lung cancer	0.000835	0.00252	CcSEcCtD
Cyclizine—Hypertension—Irinotecan—lung cancer	0.000826	0.00249	CcSEcCtD
Cyclizine—Chills—Etoposide—lung cancer	0.00082	0.00248	CcSEcCtD
Cyclizine—Vision blurred—Cisplatin—lung cancer	0.000818	0.00247	CcSEcCtD
Cyclizine—Asthenia—Vinblastine—lung cancer	0.000817	0.00247	CcSEcCtD
Cyclizine—Hypersensitivity—Topotecan—lung cancer	0.000815	0.00246	CcSEcCtD
Cyclizine—Tremor—Cisplatin—lung cancer	0.000813	0.00246	CcSEcCtD
Cyclizine—Constipation—Vinorelbine—lung cancer	0.000809	0.00244	CcSEcCtD
Cyclizine—Pain—Vinorelbine—lung cancer	0.000809	0.00244	CcSEcCtD
Cyclizine—Hypertension—Gemcitabine—lung cancer	0.000804	0.00243	CcSEcCtD
Cyclizine—Chills—Paclitaxel—lung cancer	0.000804	0.00243	CcSEcCtD
Cyclizine—Hepatobiliary disease—Docetaxel—lung cancer	0.0008	0.00242	CcSEcCtD
Cyclizine—Asthenia—Topotecan—lung cancer	0.000794	0.0024	CcSEcCtD
Cyclizine—Thrombophlebitis—Doxorubicin—lung cancer	0.000791	0.00239	CcSEcCtD
Cyclizine—Agranulocytosis—Docetaxel—lung cancer	0.000789	0.00238	CcSEcCtD
Cyclizine—Asthenia—Erlotinib—lung cancer	0.000785	0.00237	CcSEcCtD
Cyclizine—Mental disorder—Paclitaxel—lung cancer	0.000785	0.00237	CcSEcCtD
Cyclizine—Hepatic function abnormal—Doxorubicin—lung cancer	0.000784	0.00237	CcSEcCtD
Cyclizine—Pruritus—Topotecan—lung cancer	0.000783	0.00236	CcSEcCtD
Cyclizine—Anaphylactic shock—Irinotecan—lung cancer	0.00078	0.00236	CcSEcCtD
Cyclizine—Erythema—Paclitaxel—lung cancer	0.00078	0.00236	CcSEcCtD
Cyclizine—HRH1—lymph node—lung cancer	0.000777	0.018	CbGeAlD
Cyclizine—Pruritus—Erlotinib—lung cancer	0.000774	0.00234	CcSEcCtD
Cyclizine—Nervous system disorder—Irinotecan—lung cancer	0.000765	0.00231	CcSEcCtD
Cyclizine—Tension—Paclitaxel—lung cancer	0.000765	0.00231	CcSEcCtD
Cyclizine—Muscle spasms—Etoposide—lung cancer	0.000765	0.00231	CcSEcCtD
Cyclizine—Anaphylactic shock—Gemcitabine—lung cancer	0.00076	0.0023	CcSEcCtD
Cyclizine—Hepatitis—Docetaxel—lung cancer	0.000759	0.00229	CcSEcCtD
Cyclizine—Nervousness—Paclitaxel—lung cancer	0.000757	0.00229	CcSEcCtD
Cyclizine—Dizziness—Vinblastine—lung cancer	0.000753	0.00227	CcSEcCtD
Cyclizine—Convulsion—Cisplatin—lung cancer	0.000752	0.00227	CcSEcCtD
Cyclizine—Urticaria—Vinorelbine—lung cancer	0.000752	0.00227	CcSEcCtD
Cyclizine—Flunarizine—CYP2A6—lung cancer	0.00075	0.0581	CrCbGaD
Cyclizine—Muscle spasms—Paclitaxel—lung cancer	0.00075	0.00226	CcSEcCtD
Cyclizine—Connective tissue disorder—Docetaxel—lung cancer	0.000746	0.00225	CcSEcCtD
Cyclizine—Nervous system disorder—Gemcitabine—lung cancer	0.000745	0.00225	CcSEcCtD
Cyclizine—Skin disorder—Gemcitabine—lung cancer	0.000738	0.00223	CcSEcCtD
Cyclizine—Vision blurred—Paclitaxel—lung cancer	0.000735	0.00222	CcSEcCtD
Cyclizine—Dizziness—Topotecan—lung cancer	0.000731	0.00221	CcSEcCtD
Cyclizine—Tremor—Paclitaxel—lung cancer	0.000731	0.00221	CcSEcCtD
Cyclizine—Hypotension—Irinotecan—lung cancer	0.000729	0.0022	CcSEcCtD
Cyclizine—Dizziness—Erlotinib—lung cancer	0.000724	0.00219	CcSEcCtD
Cyclizine—Dermatitis bullous—Doxorubicin—lung cancer	0.000717	0.00216	CcSEcCtD
Cyclizine—Agitation—Paclitaxel—lung cancer	0.000717	0.00216	CcSEcCtD
Cyclizine—Headache—Vinblastine—lung cancer	0.000713	0.00215	CcSEcCtD
Cyclizine—Angioedema—Paclitaxel—lung cancer	0.000713	0.00215	CcSEcCtD
Cyclizine—Hypotension—Gemcitabine—lung cancer	0.00071	0.00215	CcSEcCtD
Cyclizine—Eye disorder—Docetaxel—lung cancer	0.00071	0.00214	CcSEcCtD
Cyclizine—Anaphylactic shock—Cisplatin—lung cancer	0.000709	0.00214	CcSEcCtD
Cyclizine—Insomnia—Irinotecan—lung cancer	0.000706	0.00213	CcSEcCtD
Cyclizine—Paraesthesia—Irinotecan—lung cancer	0.000701	0.00212	CcSEcCtD
Cyclizine—Hypersensitivity—Vinorelbine—lung cancer	0.000697	0.00211	CcSEcCtD
Cyclizine—Nervous system disorder—Cisplatin—lung cancer	0.000695	0.0021	CcSEcCtD
Cyclizine—Somnolence—Irinotecan—lung cancer	0.000694	0.0021	CcSEcCtD
Cyclizine—Headache—Topotecan—lung cancer	0.000693	0.00209	CcSEcCtD
Cyclizine—Tachycardia—Cisplatin—lung cancer	0.000692	0.00209	CcSEcCtD
Cyclizine—Convulsion—Etoposide—lung cancer	0.000689	0.00208	CcSEcCtD
Cyclizine—Skin disorder—Cisplatin—lung cancer	0.000688	0.00208	CcSEcCtD
Cyclizine—Insomnia—Gemcitabine—lung cancer	0.000688	0.00208	CcSEcCtD
Cyclizine—Hypertension—Etoposide—lung cancer	0.000687	0.00207	CcSEcCtD
Cyclizine—Headache—Erlotinib—lung cancer	0.000686	0.00207	CcSEcCtD
Cyclizine—Paraesthesia—Gemcitabine—lung cancer	0.000683	0.00206	CcSEcCtD
Cyclizine—Chills—Docetaxel—lung cancer	0.000681	0.00206	CcSEcCtD
Cyclizine—Asthenia—Vinorelbine—lung cancer	0.000679	0.00205	CcSEcCtD
Cyclizine—Somnolence—Gemcitabine—lung cancer	0.000676	0.00204	CcSEcCtD
Cyclizine—Convulsion—Paclitaxel—lung cancer	0.000676	0.00204	CcSEcCtD
Cyclizine—Hypertension—Paclitaxel—lung cancer	0.000673	0.00203	CcSEcCtD
Cyclizine—Pruritus—Vinorelbine—lung cancer	0.000669	0.00202	CcSEcCtD
Cyclizine—Pain—Irinotecan—lung cancer	0.000667	0.00202	CcSEcCtD
Cyclizine—Constipation—Irinotecan—lung cancer	0.000667	0.00202	CcSEcCtD
Cyclizine—Mental disorder—Docetaxel—lung cancer	0.000665	0.00201	CcSEcCtD
Cyclizine—Bifonazole—CYP2E1—lung cancer	0.000662	0.0513	CrCbGaD
Cyclizine—Hypotension—Cisplatin—lung cancer	0.000662	0.002	CcSEcCtD
Cyclizine—Erythema—Docetaxel—lung cancer	0.000661	0.002	CcSEcCtD
Cyclizine—Constipation—Gemcitabine—lung cancer	0.00065	0.00196	CcSEcCtD
Cyclizine—Pain—Gemcitabine—lung cancer	0.00065	0.00196	CcSEcCtD
Cyclizine—Anaphylactic shock—Etoposide—lung cancer	0.000649	0.00196	CcSEcCtD
Cyclizine—Anaphylactic shock—Paclitaxel—lung cancer	0.000636	0.00192	CcSEcCtD
Cyclizine—Paraesthesia—Cisplatin—lung cancer	0.000636	0.00192	CcSEcCtD
Cyclizine—Muscle spasms—Docetaxel—lung cancer	0.000635	0.00192	CcSEcCtD
Cyclizine—Tachycardia—Etoposide—lung cancer	0.000634	0.00191	CcSEcCtD
Cyclizine—Skin disorder—Etoposide—lung cancer	0.000631	0.0019	CcSEcCtD
Cyclizine—Dizziness—Vinorelbine—lung cancer	0.000626	0.00189	CcSEcCtD
Cyclizine—Nervous system disorder—Paclitaxel—lung cancer	0.000624	0.00189	CcSEcCtD
Cyclizine—Tachycardia—Paclitaxel—lung cancer	0.000621	0.00188	CcSEcCtD
Cyclizine—Skin disorder—Paclitaxel—lung cancer	0.000618	0.00187	CcSEcCtD
Cyclizine—Drowsiness—Methotrexate—lung cancer	0.00061	0.00184	CcSEcCtD
Cyclizine—Hypotension—Etoposide—lung cancer	0.000607	0.00183	CcSEcCtD
Cyclizine—Pain—Cisplatin—lung cancer	0.000606	0.00183	CcSEcCtD
Cyclizine—Hypotension—Paclitaxel—lung cancer	0.000595	0.0018	CcSEcCtD
Cyclizine—Cinnarizine—CYP2A6—lung cancer	0.000593	0.046	CrCbGaD
Cyclizine—Headache—Vinorelbine—lung cancer	0.000593	0.00179	CcSEcCtD
Cyclizine—Paraesthesia—Etoposide—lung cancer	0.000583	0.00176	CcSEcCtD
Cyclizine—Somnolence—Etoposide—lung cancer	0.000577	0.00174	CcSEcCtD
Cyclizine—Hepatobiliary disease—Methotrexate—lung cancer	0.000577	0.00174	CcSEcCtD
Cyclizine—Insomnia—Paclitaxel—lung cancer	0.000576	0.00174	CcSEcCtD
Cyclizine—Hypersensitivity—Irinotecan—lung cancer	0.000575	0.00174	CcSEcCtD
Cyclizine—Convulsion—Docetaxel—lung cancer	0.000573	0.00173	CcSEcCtD
Cyclizine—Paraesthesia—Paclitaxel—lung cancer	0.000571	0.00173	CcSEcCtD
Cyclizine—Hypertension—Docetaxel—lung cancer	0.000571	0.00172	CcSEcCtD
Cyclizine—Agranulocytosis—Methotrexate—lung cancer	0.000569	0.00172	CcSEcCtD
Cyclizine—Somnolence—Paclitaxel—lung cancer	0.000566	0.00171	CcSEcCtD
Cyclizine—Asthenia—Irinotecan—lung cancer	0.00056	0.00169	CcSEcCtD
Cyclizine—Constipation—Etoposide—lung cancer	0.000555	0.00168	CcSEcCtD
Cyclizine—Pain—Etoposide—lung cancer	0.000555	0.00168	CcSEcCtD
Cyclizine—Hepatitis—Methotrexate—lung cancer	0.000547	0.00165	CcSEcCtD
Cyclizine—Asthenia—Gemcitabine—lung cancer	0.000545	0.00165	CcSEcCtD
Cyclizine—Pain—Paclitaxel—lung cancer	0.000544	0.00164	CcSEcCtD
Cyclizine—Constipation—Paclitaxel—lung cancer	0.000544	0.00164	CcSEcCtD
Cyclizine—Anaphylactic shock—Docetaxel—lung cancer	0.000539	0.00163	CcSEcCtD
Cyclizine—Pruritus—Gemcitabine—lung cancer	0.000538	0.00162	CcSEcCtD
Cyclizine—Nervous system disorder—Docetaxel—lung cancer	0.000529	0.0016	CcSEcCtD
Cyclizine—Drowsiness—Doxorubicin—lung cancer	0.000528	0.00159	CcSEcCtD
Cyclizine—Tachycardia—Docetaxel—lung cancer	0.000526	0.00159	CcSEcCtD
Cyclizine—Flunarizine—CYP1A1—lung cancer	0.000525	0.0407	CrCbGaD
Cyclizine—Skin disorder—Docetaxel—lung cancer	0.000524	0.00158	CcSEcCtD
Cyclizine—Hypersensitivity—Cisplatin—lung cancer	0.000522	0.00158	CcSEcCtD
Cyclizine—Dizziness—Irinotecan—lung cancer	0.000516	0.00156	CcSEcCtD
Cyclizine—Urticaria—Etoposide—lung cancer	0.000516	0.00156	CcSEcCtD
Cyclizine—Eye disorder—Methotrexate—lung cancer	0.000511	0.00154	CcSEcCtD
Cyclizine—Asthenia—Cisplatin—lung cancer	0.000508	0.00154	CcSEcCtD
Cyclizine—Urticaria—Paclitaxel—lung cancer	0.000506	0.00153	CcSEcCtD
Cyclizine—Hypotension—Docetaxel—lung cancer	0.000504	0.00152	CcSEcCtD
Cyclizine—Hepatobiliary disease—Doxorubicin—lung cancer	0.000499	0.00151	CcSEcCtD
Cyclizine—Agranulocytosis—Doxorubicin—lung cancer	0.000493	0.00149	CcSEcCtD
Cyclizine—Chills—Methotrexate—lung cancer	0.000491	0.00148	CcSEcCtD
Cyclizine—Headache—Irinotecan—lung cancer	0.000489	0.00148	CcSEcCtD
Cyclizine—Insomnia—Docetaxel—lung cancer	0.000488	0.00147	CcSEcCtD
Cyclizine—Reboxetine—ABCB1—lung cancer	0.000487	0.0378	CrCbGaD
Cyclizine—Paraesthesia—Docetaxel—lung cancer	0.000484	0.00146	CcSEcCtD
Cyclizine—Somnolence—Docetaxel—lung cancer	0.00048	0.00145	CcSEcCtD
Cyclizine—Mental disorder—Methotrexate—lung cancer	0.000479	0.00145	CcSEcCtD
Cyclizine—Hypersensitivity—Etoposide—lung cancer	0.000478	0.00144	CcSEcCtD
Cyclizine—Erythema—Methotrexate—lung cancer	0.000476	0.00144	CcSEcCtD
Cyclizine—Headache—Gemcitabine—lung cancer	0.000476	0.00144	CcSEcCtD
Cyclizine—Hepatitis—Doxorubicin—lung cancer	0.000474	0.00143	CcSEcCtD
Cyclizine—Hypersensitivity—Paclitaxel—lung cancer	0.000469	0.00142	CcSEcCtD
Cyclizine—Asthenia—Etoposide—lung cancer	0.000466	0.00141	CcSEcCtD
Cyclizine—Connective tissue disorder—Doxorubicin—lung cancer	0.000466	0.00141	CcSEcCtD
Cyclizine—Pain—Docetaxel—lung cancer	0.000461	0.00139	CcSEcCtD
Cyclizine—Constipation—Docetaxel—lung cancer	0.000461	0.00139	CcSEcCtD
Cyclizine—Pruritus—Etoposide—lung cancer	0.000459	0.00139	CcSEcCtD
Cyclizine—Asthenia—Paclitaxel—lung cancer	0.000457	0.00138	CcSEcCtD
Cyclizine—Pruritus—Paclitaxel—lung cancer	0.00045	0.00136	CcSEcCtD
Cyclizine—Vision blurred—Methotrexate—lung cancer	0.000449	0.00136	CcSEcCtD
Cyclizine—Eye disorder—Doxorubicin—lung cancer	0.000443	0.00134	CcSEcCtD
Cyclizine—Dizziness—Etoposide—lung cancer	0.000429	0.0013	CcSEcCtD
Cyclizine—Chills—Doxorubicin—lung cancer	0.000425	0.00128	CcSEcCtD
Cyclizine—Dizziness—Paclitaxel—lung cancer	0.000421	0.00127	CcSEcCtD
Cyclizine—Cinnarizine—CYP1A1—lung cancer	0.000415	0.0322	CrCbGaD
Cyclizine—Mental disorder—Doxorubicin—lung cancer	0.000415	0.00125	CcSEcCtD
Cyclizine—Convulsion—Methotrexate—lung cancer	0.000413	0.00125	CcSEcCtD
Cyclizine—Erythema—Doxorubicin—lung cancer	0.000413	0.00125	CcSEcCtD
Cyclizine—Headache—Etoposide—lung cancer	0.000407	0.00123	CcSEcCtD
Cyclizine—Tension—Doxorubicin—lung cancer	0.000405	0.00122	CcSEcCtD
Cyclizine—Nervousness—Doxorubicin—lung cancer	0.000401	0.00121	CcSEcCtD
Cyclizine—Headache—Paclitaxel—lung cancer	0.000399	0.0012	CcSEcCtD
Cyclizine—Hypersensitivity—Docetaxel—lung cancer	0.000397	0.0012	CcSEcCtD
Cyclizine—Muscle spasms—Doxorubicin—lung cancer	0.000397	0.0012	CcSEcCtD
Cyclizine—Anaphylactic shock—Methotrexate—lung cancer	0.000389	0.00117	CcSEcCtD
Cyclizine—Vision blurred—Doxorubicin—lung cancer	0.000389	0.00117	CcSEcCtD
Cyclizine—Asthenia—Docetaxel—lung cancer	0.000387	0.00117	CcSEcCtD
Cyclizine—Pruritus—Docetaxel—lung cancer	0.000382	0.00115	CcSEcCtD
Cyclizine—Nervous system disorder—Methotrexate—lung cancer	0.000381	0.00115	CcSEcCtD
Cyclizine—Agitation—Doxorubicin—lung cancer	0.000379	0.00115	CcSEcCtD
Cyclizine—Skin disorder—Methotrexate—lung cancer	0.000378	0.00114	CcSEcCtD
Cyclizine—Hypotension—Methotrexate—lung cancer	0.000363	0.0011	CcSEcCtD
Cyclizine—Convulsion—Doxorubicin—lung cancer	0.000357	0.00108	CcSEcCtD
Cyclizine—Dizziness—Docetaxel—lung cancer	0.000357	0.00108	CcSEcCtD
Cyclizine—Hypertension—Doxorubicin—lung cancer	0.000356	0.00108	CcSEcCtD
Cyclizine—Insomnia—Methotrexate—lung cancer	0.000352	0.00106	CcSEcCtD
Cyclizine—Paraesthesia—Methotrexate—lung cancer	0.000349	0.00105	CcSEcCtD
Cyclizine—Somnolence—Methotrexate—lung cancer	0.000346	0.00104	CcSEcCtD
Cyclizine—Clozapine—CYP2A6—lung cancer	0.000344	0.0266	CrCbGaD
Cyclizine—Headache—Docetaxel—lung cancer	0.000338	0.00102	CcSEcCtD
Cyclizine—Anaphylactic shock—Doxorubicin—lung cancer	0.000337	0.00102	CcSEcCtD
Cyclizine—Pain—Methotrexate—lung cancer	0.000332	0.001	CcSEcCtD
Cyclizine—Nervous system disorder—Doxorubicin—lung cancer	0.00033	0.000997	CcSEcCtD
Cyclizine—Phenprocoumon—ALB—lung cancer	0.000329	0.0255	CrCbGaD
Cyclizine—Tachycardia—Doxorubicin—lung cancer	0.000329	0.000992	CcSEcCtD
Cyclizine—Skin disorder—Doxorubicin—lung cancer	0.000327	0.000988	CcSEcCtD
Cyclizine—Hypotension—Doxorubicin—lung cancer	0.000315	0.00095	CcSEcCtD
Cyclizine—Urticaria—Methotrexate—lung cancer	0.000309	0.000933	CcSEcCtD
Cyclizine—Insomnia—Doxorubicin—lung cancer	0.000305	0.00092	CcSEcCtD
Cyclizine—Paraesthesia—Doxorubicin—lung cancer	0.000302	0.000913	CcSEcCtD
Cyclizine—Somnolence—Doxorubicin—lung cancer	0.000299	0.000904	CcSEcCtD
Cyclizine—Pain—Doxorubicin—lung cancer	0.000288	0.00087	CcSEcCtD
Cyclizine—Constipation—Doxorubicin—lung cancer	0.000288	0.00087	CcSEcCtD
Cyclizine—Hypersensitivity—Methotrexate—lung cancer	0.000286	0.000865	CcSEcCtD
Cyclizine—Orphenadrine—CYP2E1—lung cancer	0.000286	0.0222	CrCbGaD
Cyclizine—Asthenia—Methotrexate—lung cancer	0.000279	0.000843	CcSEcCtD
Cyclizine—Pruritus—Methotrexate—lung cancer	0.000275	0.000831	CcSEcCtD
Cyclizine—Urticaria—Doxorubicin—lung cancer	0.000267	0.000808	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—TYMS—lung cancer	0.000258	0.000795	CbGpPWpGaD
Cyclizine—Dizziness—Methotrexate—lung cancer	0.000257	0.000777	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—GSTM1—lung cancer	0.000255	0.000785	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—GRP—lung cancer	0.000253	0.000778	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—OXTR—lung cancer	0.000253	0.000778	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTT1—lung cancer	0.000253	0.000777	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP2A6—lung cancer	0.00025	0.000768	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GCLC—lung cancer	0.00025	0.000768	CbGpPWpGaD
Cyclizine—Hypersensitivity—Doxorubicin—lung cancer	0.000248	0.000749	CcSEcCtD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000244	0.000751	CbGpPWpGaD
Cyclizine—Clozapine—CYP2E1—lung cancer	0.000244	0.0189	CrCbGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	0.000244	0.00075	CbGpPWpGaD
Cyclizine—Headache—Methotrexate—lung cancer	0.000244	0.000736	CcSEcCtD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	0.000243	0.000748	CbGpPWpGaD
Cyclizine—Bepridil—ABCB1—lung cancer	0.000243	0.0188	CrCbGaD
Cyclizine—SULT1E1—Metabolism—CYP1A1—lung cancer	0.000242	0.000745	CbGpPWpGaD
Cyclizine—Asthenia—Doxorubicin—lung cancer	0.000242	0.00073	CcSEcCtD
Cyclizine—Clozapine—CYP1A1—lung cancer	0.000241	0.0187	CrCbGaD
Cyclizine—SULT1E1—Metabolism—ERCC2—lung cancer	0.00024	0.000739	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—PIK3CA—lung cancer	0.00024	0.000737	CbGpPWpGaD
Cyclizine—Pruritus—Doxorubicin—lung cancer	0.000238	0.000719	CcSEcCtD
Cyclizine—HRH1—GPCR ligand binding—GNG11—lung cancer	0.000237	0.000728	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000232	0.000712	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000229	0.000703	CbGpPWpGaD
Cyclizine—Fentanyl—ABCB1—lung cancer	0.000223	0.0173	CrCbGaD
Cyclizine—Dizziness—Doxorubicin—lung cancer	0.000223	0.000672	CcSEcCtD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000214	0.000659	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP2E1—lung cancer	0.000213	0.000653	CbGpPWpGaD
Cyclizine—Headache—Doxorubicin—lung cancer	0.000211	0.000637	CcSEcCtD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	0.00021	0.000644	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—APOA1—lung cancer	0.000208	0.000639	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GIPR—lung cancer	0.000204	0.000628	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—PTHLH—lung cancer	0.000198	0.000609	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—AKT1—lung cancer	0.000196	0.000602	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CG—lung cancer	0.00019	0.000583	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ANXA1—lung cancer	0.000186	0.000572	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GIPR—lung cancer	0.000185	0.00057	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—POMC—lung cancer	0.000181	0.000555	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.00018	0.000554	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000178	0.000546	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—APP—lung cancer	0.000176	0.000542	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CREBBP—lung cancer	0.000176	0.000541	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTP1—lung cancer	0.000175	0.000539	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GRM8—lung cancer	0.000174	0.000534	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	0.000173	0.000531	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CD—lung cancer	0.000167	0.000513	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ALB—lung cancer	0.000165	0.000506	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTM1—lung cancer	0.000161	0.000495	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	0.000159	0.000488	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	0.000158	0.000485	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GRM8—lung cancer	0.000158	0.000485	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP1A1—lung cancer	0.000153	0.000469	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	0.000151	0.000463	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	0.00015	0.000462	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CB—lung cancer	0.000145	0.000447	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AXL—lung cancer	0.000144	0.000444	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PTGS2—lung cancer	0.000144	0.000443	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GRP—lung cancer	0.000143	0.000439	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—OXTR—lung cancer	0.000143	0.000439	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—AVP—lung cancer	0.000137	0.000422	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—COL4A3BP—lung cancer	0.000134	0.000413	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AZIN2—lung cancer	0.000134	0.000413	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GNG11—lung cancer	0.000134	0.000411	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.000133	0.00041	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GRP—lung cancer	0.00013	0.000399	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—OXTR—lung cancer	0.00013	0.000399	CbGpPWpGaD
Cyclizine—Clozapine—ABCB1—lung cancer	0.000128	0.00992	CrCbGaD
Cyclizine—SULT1E1—Metabolism—PTEN—lung cancer	0.000126	0.000386	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000125	0.000385	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GNG11—lung cancer	0.000122	0.000374	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000121	0.000373	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADCY1—lung cancer	0.00012	0.00037	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—EP300—lung cancer	0.00012	0.000368	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.00012	0.000368	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ATP5H—lung cancer	0.000114	0.000351	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—POMC—lung cancer	0.000114	0.00035	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—COL4A2—lung cancer	0.000112	0.000346	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PTHLH—lung cancer	0.000112	0.000344	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GIPR—lung cancer	0.00011	0.000337	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADCY1—lung cancer	0.000109	0.000336	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PPP2R1B—lung cancer	0.000106	0.000327	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ANXA1—lung cancer	0.000105	0.000323	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000105	0.000323	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SDC4—lung cancer	0.000102	0.000314	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLBD1—lung cancer	0.000102	0.000313	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PTHLH—lung cancer	0.000102	0.000312	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.0001	0.000309	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DUSP3—lung cancer	0.0001	0.000308	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.0001	0.000308	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—APP—lung cancer	9.97e-05	0.000307	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RHEB—lung cancer	9.82e-05	0.000302	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	9.61e-05	0.000295	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ANXA1—lung cancer	9.55e-05	0.000294	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GRM8—lung cancer	9.31e-05	0.000286	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD17B10—lung cancer	9.31e-05	0.000286	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	9.26e-05	0.000285	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	9.14e-05	0.000281	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—POMC—lung cancer	9.12e-05	0.00028	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—APP—lung cancer	9.05e-05	0.000278	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SKI—lung cancer	9.02e-05	0.000277	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—PIK3CA—lung cancer	8.87e-05	0.000273	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CA—lung cancer	8.86e-05	0.000272	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CKB—lung cancer	8.65e-05	0.000266	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	8.64e-05	0.000266	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM2—lung cancer	8.14e-05	0.00025	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CNDP2—lung cancer	8.14e-05	0.00025	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	7.93e-05	0.000244	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTMR3—lung cancer	7.91e-05	0.000243	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PXN—lung cancer	7.83e-05	0.000241	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AVP—lung cancer	7.75e-05	0.000238	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PGAM1—lung cancer	7.71e-05	0.000237	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKR1C1—lung cancer	7.67e-05	0.000236	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GRP—lung cancer	7.67e-05	0.000236	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—OXTR—lung cancer	7.67e-05	0.000236	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2A7—lung cancer	7.36e-05	0.000226	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	7.34e-05	0.000226	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKT1—lung cancer	7.24e-05	0.000223	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SDC4—lung cancer	7.2e-05	0.000221	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNG11—lung cancer	7.18e-05	0.000221	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CXCL8—lung cancer	7.05e-05	0.000217	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AVP—lung cancer	7.04e-05	0.000216	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	7.03e-05	0.000216	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFC—lung cancer	6.83e-05	0.00021	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTA3—lung cancer	6.56e-05	0.000202	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—RRM1—lung cancer	6.56e-05	0.000202	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADCY1—lung cancer	6.45e-05	0.000198	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PPP2R1B—lung cancer	6.29e-05	0.000193	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SMARCA4—lung cancer	6.29e-05	0.000193	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—B4GALT5—lung cancer	6.17e-05	0.00019	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HSPB1—lung cancer	6.07e-05	0.000187	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTHLH—lung cancer	6e-05	0.000184	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTA4—lung cancer	6e-05	0.000184	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.86e-05	0.00018	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTA2—lung cancer	5.85e-05	0.00018	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ANXA1—lung cancer	5.64e-05	0.000173	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTA1—lung cancer	5.64e-05	0.000173	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCC3—lung cancer	5.58e-05	0.000171	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FLT1—lung cancer	5.46e-05	0.000168	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	5.41e-05	0.000166	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKR1C1—lung cancer	5.4e-05	0.000166	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APP—lung cancer	5.35e-05	0.000164	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH3—lung cancer	5.35e-05	0.000164	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF9—lung cancer	5.3e-05	0.000163	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—UGT1A1—lung cancer	5.24e-05	0.000161	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—POMC—lung cancer	5.15e-05	0.000158	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JUNB—lung cancer	5.06e-05	0.000156	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GNG11—lung cancer	5.06e-05	0.000155	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.03e-05	0.000155	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	4.91e-05	0.000151	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDOA—lung cancer	4.81e-05	0.000148	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	4.76e-05	0.000146	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—POMC—lung cancer	4.68e-05	0.000144	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCOA3—lung cancer	4.67e-05	0.000144	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STK11—lung cancer	4.6e-05	0.000141	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.59e-05	0.000141	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6R—lung cancer	4.56e-05	0.00014	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCG2—lung cancer	4.55e-05	0.00014	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADCY1—lung cancer	4.55e-05	0.00014	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ENO2—lung cancer	4.46e-05	0.000137	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HPGDS—lung cancer	4.46e-05	0.000137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FOXO3—lung cancer	4.44e-05	0.000136	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.43e-05	0.000136	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.37e-05	0.000134	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	4.35e-05	0.000134	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTT1—lung cancer	4.32e-05	0.000133	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	4.32e-05	0.000133	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCLC—lung cancer	4.27e-05	0.000131	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2A6—lung cancer	4.27e-05	0.000131	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.26e-05	0.000131	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AVP—lung cancer	4.16e-05	0.000128	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	4.15e-05	0.000128	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ENO1—lung cancer	4.05e-05	0.000125	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.04e-05	0.000124	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1R—lung cancer	4e-05	0.000123	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	3.99e-05	0.000123	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.99e-05	0.000123	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HES1—lung cancer	3.93e-05	0.000121	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RAF1—lung cancer	3.86e-05	0.000119	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—IL2—lung cancer	3.81e-05	0.000117	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	3.77e-05	0.000116	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2E1—lung cancer	3.63e-05	0.000112	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCL8—lung cancer	3.62e-05	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ERBB3—lung cancer	3.6e-05	0.000111	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NQO1—lung cancer	3.59e-05	0.00011	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.52e-05	0.000108	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.49e-05	0.000107	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL2—lung cancer	3.46e-05	0.000106	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TERT—lung cancer	3.45e-05	0.000106	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGFR1—lung cancer	3.35e-05	0.000103	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HIF1A—lung cancer	3.3e-05	0.000101	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—STK11—lung cancer	3.24e-05	9.96e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOA1—lung cancer	3.18e-05	9.78e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KDR—lung cancer	3.15e-05	9.69e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.04e-05	9.35e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTP1—lung cancer	3e-05	9.22e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAT—lung cancer	2.92e-05	8.97e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APC—lung cancer	2.9e-05	8.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CG—lung cancer	2.9e-05	8.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KIT—lung cancer	2.9e-05	8.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—NRAS—lung cancer	2.9e-05	8.93e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.9e-05	8.92e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGF—lung cancer	2.87e-05	8.82e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCB1—lung cancer	2.84e-05	8.72e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TYMS—lung cancer	2.79e-05	8.57e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MAPK3—lung cancer	2.78e-05	8.55e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—POMC—lung cancer	2.76e-05	8.5e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM1—lung cancer	2.75e-05	8.47e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BRAF—lung cancer	2.73e-05	8.39e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6R—lung cancer	2.7e-05	8.29e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CREBBP—lung cancer	2.69e-05	8.28e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EGFR—lung cancer	2.65e-05	8.13e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP1A1—lung cancer	2.61e-05	8.03e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ERCC2—lung cancer	2.59e-05	7.96e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAP2K1—lung cancer	2.57e-05	7.9e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CD—lung cancer	2.55e-05	7.85e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	2.53e-05	7.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KRAS—lung cancer	2.5e-05	7.68e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	2.3e-05	7.06e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MDM2—lung cancer	2.29e-05	7.03e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RAF1—lung cancer	2.28e-05	7.01e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ERBB2—lung cancer	2.25e-05	6.93e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA1—lung cancer	2.24e-05	6.89e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MTOR—lung cancer	2.22e-05	6.84e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CB—lung cancer	2.22e-05	6.84e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.15e-05	6.6e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL8—lung cancer	2.14e-05	6.57e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HRAS—lung cancer	2.12e-05	6.53e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT1—lung cancer	2.07e-05	6.35e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CASP3—lung cancer	2.05e-05	6.29e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CG—lung cancer	2.05e-05	6.29e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL2—lung cancer	2.04e-05	6.28e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—lung cancer	2.03e-05	6.25e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCND1—lung cancer	1.99e-05	6.12e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JUN—lung cancer	1.99e-05	6.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—POMC—lung cancer	1.95e-05	5.99e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP9—lung cancer	1.93e-05	5.95e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.93e-05	5.92e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTEN—lung cancer	1.92e-05	5.91e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CREBBP—lung cancer	1.9e-05	5.83e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT1—lung cancer	1.88e-05	5.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EP300—lung cancer	1.83e-05	5.64e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CD—lung cancer	1.8e-05	5.53e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SRC—lung cancer	1.78e-05	5.48e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALB—lung cancer	1.77e-05	5.46e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—lung cancer	1.74e-05	5.34e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT3—lung cancer	1.72e-05	5.29e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NRAS—lung cancer	1.72e-05	5.27e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK3—lung cancer	1.64e-05	5.05e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MYC—lung cancer	1.6e-05	4.91e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CB—lung cancer	1.57e-05	4.82e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGFR—lung cancer	1.56e-05	4.8e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS2—lung cancer	1.55e-05	4.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KRAS—lung cancer	1.48e-05	4.54e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.36e-05	4.17e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTEN—lung cancer	1.35e-05	4.16e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TP53—lung cancer	1.31e-05	4.03e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—EP300—lung cancer	1.29e-05	3.97e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HRAS—lung cancer	1.25e-05	3.86e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—lung cancer	1.2e-05	3.69e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT1—lung cancer	1.11e-05	3.41e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CA—lung cancer	9.55e-06	2.94e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKT1—lung cancer	7.8e-06	2.4e-05	CbGpPWpGaD
